Oncologia

Revisão | Prevenção e tratamento de náusea e vômito durante a terapia oncológica.

6 Set, 2022 | 12:51h

The Prevention and Treatment of Nausea and Vomiting During Tumor Therapy – Deutsches Ärzteblatt International

Conteúdos relacionados:

SEOM clinical guideline emesis (2021) – Clinical and Translational Oncology

M-A: Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy.

Prevention of Chemotherapy-Induced Nausea and Vomiting in the Older Patient: Optimizing Outcomes – Drugs & Aging (se o acesso a este link for pago, tente este)

Análise de seguimento de 30 meses de um estudo randomizado | Pembrolizumabe vs. placebo como terapia adjuvante pós-nefrectomia para carcinoma de células renais claras.

6 Set, 2022 | 12:47h

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial – The Lancet Oncology

Comentário convidado: Adjuvant immunotherapy for renal cell carcinoma – The Lancet Oncology

Artigo original: Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma – New England Journal of Medicine

Estudo randomizado | Telaglenastate falhou em melhorar a eficácia do cabozantinibe em pacientes com carcinoma de célula renal avançado.

6 Set, 2022 | 12:46h

Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial – JAMA Oncology (gratuito por tempo limitado)

Comentário no Twitter

The CANTATA randomized trial of the glutaminase inhibitor telagenastat or placebo added to cabozantinib in patients with metastatic clear cell renal cell carcinoma (RCC) demonstrated no improvement in efficacy with addition of telagenastat https://t.co/r9j2wmjnlF #GUCSM pic.twitter.com/ovXXEAXqi0

— JAMA Oncology (@JAMAOnc) September 1, 2022

Revisão sistemática | Ultrassonografia melhorada por contraste para diagnóstico de carcinoma hepatocelular em adultos com doença hepática crônica.

6 Set, 2022 | 12:41h

Contrast‐enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease – Cochrane Library

Resumo: How accurate are contrast-enhanced ultrasound scans for detecting hepatocellular carcinoma? – Cochrane Library

Estudo randomizado | Autoamostragem de HPV entre não participantes de rastreamento de câncer de colo do útero.

29 Ago, 2022 | 17:54h

HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial – British Journal of Cancer

Comentário no Twitter

Pragmatic randomised controlled trial of 3 different HPV screening approaches suggests that opt-in and particularlly send-to-all self-sampling increased participation among long-term, higher-risk non-attenders: https://t.co/hBouqoBMnU #GynCSM #hsronc

— NatureRevClinOncol (@NatRevClinOncol) August 25, 2022

Diretrizes de prática clínica para colangiocarcinoma intra-hepático.

29 Ago, 2022 | 17:46h

Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma – Liver Cancer

Diretrizes para diagnóstico e tratamento do carcinoma hepatocelular com trombose tumoral da veia porta.

29 Ago, 2022 | 17:45h

Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition) – Liver Cancer

Amostra endocervical de mulheres com suspeita de câncer de colo do útero: revisão sistemática e metanálise de estudos de acurácia de testes diagnósticos.

29 Ago, 2022 | 17:44h

Endocervical sampling in women with suspected cervical neoplasia: a systematic review and meta-analysis of diagnostic test accuracy studies – American Journal of Obstetrics & Gynecology

Revisão sistemática | Histerectomia com radioterapia ou quimioterapia ou ambas para mulheres com câncer de colo do útero localmente avançado.

29 Ago, 2022 | 17:38h

Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer – Cochrane Library

Resumo: Hysterectomy with medical management for cervical cancer that has spread to nearby tissues only – Cochrane Library

Estudo randomizado | Talimogene Laherparepvec com pembrolizumabe não é melhor que placebo-pembrolizumabe em pacientes com melanoma avançado.

29 Ago, 2022 | 17:35h

Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma – Journal of Clinical Oncology